Comparative efficacy of a high or low dose of interferon 2b in chronic hepatitis C: A randomized controlled trial

American Journal of Gastroenterology

Volumn 91, Issue 9, 1996, Pages 1734-1738

  Tassopoulos, Nicolaos C ^a  

^a Western Attica General Hospital   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FIBROSIS; FOLLOW UP; GENOTYPE; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT PLANNING;

ADULT; ANTIVIRAL AGENTS; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; LOGISTIC MODELS; MALE; PROGNOSIS; TIME FACTORS;

EID: 0029819715     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Davis GL, Baiart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant Interferon alfa: A multicenter, randomized, controlled trial. N Engl J Med 1989;321:1501-6.
2. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon-alfa therapy for chronic hepatitis C. A randomized double-blind, placebo controlled trial. N Engl J Med 1989;321:1506-10.
3. Marcellin P, Boyer N, Giostra E, et al. Recombinant human a-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France. Hepatology 1991;13:393-7.